
|Articles|February 5, 2013
Novel TB Vaccine Fails to Protect Infants
Advertisement
A tuberculosis (TB) vaccine candidate was safe and immunogenic but not efficacious in infants, researchers reported.
In a randomized trial of 2,797 infants, the vaccine candidate was well-tolerated compared with a placebo injection and induced "modest" cell-mediated immune responses, according to Helen McShane, MD, of the University of Oxford, and colleagues.
Read the full story:
Source: Medpage Today
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
AbbVie Joins Trump Drug Pricing Effort, Pledges $100B in US R&D Investment
2
Medical Debt Emerges as Risk Factor for Housing Instability
3
OpenAI for Healthcare Aims to Streamline Clinical Workflows, Reduce Administrative Burden
4
Recurrent Thymoma With MG Effectively Treated With Methylprednisolone
5




























































